Skip to main content
Glama

nvd

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. Added

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/openWorld/idempotent annotations, the description discloses many behaviors: the fan-out across multiple sources, the semantics of sources_used/sources_failed, the USPTO PatentsView API sunset soft-fail, expected empty fda_products for small-molecule-only companies, and the resolved:false path for private companies. This is rich, non-obvious behavioral context that the annotations do not capture.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but every sentence carries information about a complex multi-source tool with many return fields and edge cases. It is well-structured: purpose and preference rule are front-loaded, followed by output sections, input shapes, and failure semantics, with no meaningful redundancy.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description must document return values, and it does so thoroughly: it lists every result section (cik, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI) and explains sources_used/sources_failed. It also covers input resolution, private-company behavior, and expected empty sections, leaving little to infer.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, giving a baseline of 3. The description adds beyond the schema by clarifying that type is effectively an alias ('company' or 'ticker' are interchangeable), giving concrete input examples including a zero-padded CIK, and noting upcoming person/place support. These details help an agent construct valid parameter values.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: build a full cross-source profile of a US public company. It distinguishes itself from single-pack lookups and sibling tools by its holistic aggregation behavior, making it clear what the tool is for.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It provides explicit trigger examples ('Tell me about X', 'brief me on Tesla') and an explicit rule: ALWAYS PREFER this tool over chaining single-pack SEC/XBRL/news lookups when a holistic view is requested. It also covers when the tool is not applicable (private companies) and when empty sections are expected, giving clear when-to-use and when-not-to-use guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All nvd toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation4/5

Most tools have distinct purposes, but some overlap exists (e.g., ask_pipeworx and ask_pipeworx_grounded, deep_research and ask_pipeworx). The Polymarket tools are numerous but clearly differentiated.

Naming Consistency3/5

Mixed naming conventions: some tools start with verbs (ask_pipeworx, search_cves), others with nouns (entity_profile, recent_changes). Prefixes (pipeworx_, polymarket_) help but the pattern is not uniform.

Tool Count2/5

33 tools is excessive for a single server, covering too many domains (NVD, Pipeworx, Polymarket, SEC, memory). This reduces coherence and makes it hard for agents to navigate.

Completeness4/5

Core workflows are covered: CVE lookup, company research, prediction market analysis, and data querying. However, there are minor gaps (e.g., no tool for editing stored data, no CVE metrics beyond search).

Resources